
Dragan J Golijanin MD
Minimally Invasive Surgery, Surgical Oncology
Assistant Professor, Surgery, Brown University Program in Medicine
Join to view full profile
2 Dudley StSte 185Providence, RI 02905
Phone+1 401-421-0710
Fax+1 401-444-6947
Dr. Golijanin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dragan Golijanin, MD, is a director of the Minimally Invasive Urology Institute and director of Genitourinary Oncology at The Miriam Hospital. He also serves as an associate professor of surgery (urology) at The Warren Alpert Medical School of Brown University. His areas of expertise include prostate cancer, kidney cancer, bladder cancer and testicular cancer. Golijanin is board certified in urology.
Golijanin earned his medical degree at the University of Belgrade. He completed residencies at the University of Rochester School of Medicine, University Clinical Center in Belgrade and Hadassah Medical Center. He completed fellowships in urologic oncology at Memorial Sloan-Kettering Cancer Center and Cornell University and Hadassah Medical Center, and was the first to publish on near-infrared real-time imaging in open laparoscopic and robotic surgery.
Education & Training
University of Rochester Medical CenterResidency, Urology, 2004 - 2009
University of Rochester Medical CenterInternship, Surgery, 2003 - 2004
University of Rochester Medical CenterInternship, Transitional Year, 2003 - 2004
Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2000 - 2003
Hadassah Medical CenterUrology Residency, 1995 - 1999
Certifications & Licensure
RI State Medical License 2011 - 2028
NY State Medical License 2006 - 2013
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2014-2017
- CMS Meaningful Use Stage 2 Certification eClinicalWorks, eClinicalWorks, LLC, 2014-2017
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
Publications & Presentations
PubMed
- Optimising postoperative care: Same-day discharge after transurethral resection of the prostate.Kamil Malshy, Alejandra Balen, Borivoj Golijanin, Maximilian Jentzsch, Rachel Greenberg
Journal of Perioperative Practice. 2026-05-01 - BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).Andre L De Souza, Matthew J Hadfield, Shaolei Lu, Dragan J Golijanin, Roxanne Wood
Cancer Research Communications. 2025-12-01 - 19 citationsUrinary Tumor DNA-based Liquid Biopsy in Bladder Cancer Management: A Systematic Review.Joanne Lee, Fei Chen, Antonio Lopez-Beltran, Andrea Necchi, Alessia Cimadamore
European Urology Focus. 2025-11-01
Journal Articles
- The Association of Lymph Node Dissection with 30-Day Perioperative Morbidity Among Men Undergoing Minimally Invasive Radical Prostatectomy: Analysis of the National Su...Anthony Mega, Joseph 2nd Renzulli, Gyan Pareek, Boris Gershman, Ali Amin, Dragan Golijanin, Nature
Press Mentions
Molecular Delivery System Developed at URI Shows Promise Against Bladder CancerSeptember 19th, 2022- New Registry Aims to Find Out Why RI Has Highest Incidence of Bladder Cancer Per CapitaNovember 5th, 2020
Miriam First in New England to Do Completely Laparoscopic Robotic-Assisted Surgery for Bladder CancerOctober 12th, 2016
Other Languages
- French, Hebrew, Croatian, Serbian, Bosnian
External Links
- Minimally Invasive Urology Institute at The Miriam Hospitalhttps://www.lifespan.org/centers-services/minimally-invasive-urology-institute
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:


